GP Specialists has been manufacturing and advancing Ortho-k lens design technology for nearly 20 years.
This industry experience has lead to the development of a simplified patient fitting process and an enhanced patient experience.
GP Specialists’ contact lenses for corneal refractive therapy were FDA approved in the Spring of 2002.* Lenses may be worn for night therapy with normal cleaning and disinfecting upon removal as recommended by the eye care practitioner.
GP Specialists’ Corneal Reshaping Lenses Unique formulated designs will apply gentle pressure on the tear layer decreasing the center thickness of the cornea. If the treatment is discontinued the process is reversed.
There is no age restriction. Ortho-k contact lenses are safe, effective, predictable and reversible.
Advanced 21st century manufacturing technology with advanced Ortho-k designs have led to improved Ortho-K lens performance. The initial myopia correction process that once took weeks to achieve now may be accomplished in a very short time. Patients with lower degrees of myopia may be corrected overnight. Higher degrees of myopia maybe corrected within a week.
The goal is to correct Myopia and improve vision for the life-style choice of your patient. Enhanced vision provides freedom and confidence for daily activity.
We’ll help you find a local eye doctor for a Free Orthokeratology Evaluation
Transition Reverse Zone is steeper in proportion to the target refraction and the pretreatment central ‘K’.
Control Surface System Aids in positioning on pupil center.
Orthokeratology treatment for use in the reduction of myopic refractive error in non-diseased eyes. GP Specialists iSee2 Ortho-k lenses use Boston Equalens II materials as indicated for FDA approved night wear in the corneal reshaping orthokeratology fitting program.
When selecting this procedure, keep in mind the continuing ocular health of the patient, and lens performance on the eye should be carefully monitored by the prescribing eye care practitioner.
Every possible complication may not be seen in initial clinical studies.
The amount of reduction will depend on:
Reduction for any individual patient’s myopia may vary depending on that patient’s corneal variables.
All serious adverse experiences and adverse reactions observed in patients wearing or experienced with the lenses should be reported to the manufacturer immediately.
*For complete FDA approved parameters and practitioner designed lenses call 800-889-0379.